Advanced search
Publication Cover
The World Journal of Biological Psychiatry Volume 10, 2009 - Issue 4-3
Submit an article Journal homepage
396
Views
9
CrossRef citations to date
0
Altmetric
Original Investigations

Olanzapine orally disintegrating tablets (Zyprexa ZydisR) rapidly improve excitement components in the acute phase of first-episode schizophrenic patients: An open-label prospective study

Hikaru Hori Department of Psychiatry, School of Medicine, University of Occupational and Environmental Health, Iseigaoka, Yahatanishiku, Kitakyusyu, Fukuoka, Japan
,
Nobuhisa Ueda Department of Psychiatry, School of Medicine, University of Occupational and Environmental Health, Iseigaoka, Yahatanishiku, Kitakyusyu, Fukuoka, Japan
,
Reiji Yoshimura Department of Psychiatry, School of Medicine, University of Occupational and Environmental Health, Iseigaoka, Yahatanishiku, Kitakyusyu, Fukuoka, JapanCorrespondence[email protected]
,
Hiroshi Yamamoto Yahatakousei Hospital, Kitakyushu, Fukuoka, Japan
,
Kenta Wani Yahatakousei Hospital, Kitakyushu, Fukuoka, Japan
,
Yoshinori Etoh Komine Etoh Hospital, Kitakyushu, Fukuoka, Japan
,
Kensuke Haraga Orio Hospital, Kitakyushu, Fukuoka, Japan
,
Junichi Kitahara Hiagari Hospital, Kitakyushu, Fukuoka, Japan
&
Jun Nakamura Department of Psychiatry, School of Medicine, University of Occupational and Environmental Health, Iseigaoka, Yahatanishiku, Kitakyusyu, Fukuoka, Japan
 show all
Pages 741-745 | Received 07 May 2009, Published online: 08 Dec 2009

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

William Montgomery, Tamas Treuer, Jamie Karagianis, Haya Ascher-Svanum & Gavan Harrison. (2012) Orally disintegrating olanzapine review: effectiveness, patient preference, adherence, and other properties. Patient Preference and Adherence 6, pages 109-125.
Read now
Dennis Douroumis. (2011) Orally disintegrating dosage forms and taste-masking technologies; 2010. Expert Opinion on Drug Delivery 8:5, pages 665-675.
Read now

Articles from other publishers (7)

. (2021) Japanese Society of Neuropsychopharmacology: “Guideline for Pharmacological Therapy of Schizophrenia”. Neuropsychopharmacology Reports 41:3, pages 266-324.
Crossref
Lin Fan, Lizhi Zhang, Hongquan Zheng, Junlin Cheng, Yunfang Hu, Jianghui Liu & Hongwei Fan. (2020) Pharmacokinetics and Bioequivalence of 2 Olanzapine Orally Disintegrating Tablet Products in Healthy Chinese Subjects Under Fed and Fasting Conditions. Clinical Pharmacology in Drug Development 9:5, pages 593-601.
Crossref
Kishor V. Kande, Darsheen J. Kotak, Mariam S. Degani, Dmitry Kirsanov, Andrey Legin & Padma V. Devarajan. (2016) Microwave-Assisted Development of Orally Disintegrating Tablets by Direct Compression. AAPS PharmSciTech 18:6, pages 2055-2066.
Crossref
Hikaru Hori, Nobuhisa Ueda, Hideki Shiozuka, Ryohei Igata, Tazuko Miki, Kiyokazu Atake, Yuji Takeuchi, Hiroaki Shirozu, Naotoshi Ohara, Yuki Konishi, Hiroshi Nagai, Noriaki Sakurai, Takanori Kubota & Reiji Yoshimura. (2016) The Nursing Assessment of Medication Acceptance: the reliability and validity of a schizophrenia medication adherence scale. Therapeutic Advances in Psychopharmacology 7:1, pages 11-16.
Crossref
Cenk Tek, Suat Kucukgoncu, Sinan Guloksuz, Scott W. Woods, Vinod H. Srihari & Aniyizhai Annamalai. (2016) Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications. Early Intervention in Psychiatry 10:3, pages 193-202.
Crossref
Maarten Bak, Annemarie Fransen, Jouke Janssen, Jim van Os & Marjan Drukker. (2014) Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis. PLoS ONE 9:4, pages e94112.
Crossref
Kimberly Nordstrom & Michael H. Allen. (2013) Alternative Delivery Systems for Agents to Treat Acute Agitation: Progress to Date. Drugs 73:16, pages 1783-1792.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.